We previously identified, in our global cohort of 103 bladder cancer samples, high frequencies of two non-coding mutational hotspots: intron 6 of GPR126 in 45.6% [17] and PLEKHS1 promoter in 29.1% [18]. Here, PLEKHS1 is linked to urinary bladder carcinoma.